On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now

Blog


Simply Sonoma Inc. Developing High-Quality, All-Natural CBD-Infused Beverages for Entry into Growing Market

  • CBD-infused beverages market expected to make over $14,600 million by the end of 2026
  • CBD beverages are becoming more popular as cannabis-infused goods become legalized across the United States and around the world
  • Simply Sonoma has two CBD-infused beverages on the docket: an alcohol-free, CBD wine product and a low-carb, low-sugar CBD sparkling product
Cannabidiol, or CBD, is gaining the attention of enthusiastic cannabis consumers around the world. The list of products that contain CBD is growing, with one of the most popular new products being CBD-infused beverages. Simply Sonoma, a company committed to offering CBD products for the environmentally conscious consumer, is branching out into the beverage space with an alcohol-free, CBD wine product as well as low-carb, low-sugar Pinot Noir/CBD sparkling product. “The global CBD-infused beverages market was valued at around USD$3,400 million in 2020 and is expected to make over USD$14,600 million by the end of 2026, with a CAGR of approximately 27.5% between 2021 and 2026,” reported Facts and Factors (https://ibn.fm/D3gas). “The market for CBD-infused drinks is largely driven by the rising authorization and certification for recreational cannabis in countries, such as the United States and Canada. “Furthermore, because of the increasing incidence of numerous respiratory disorders, there is a growing movement away from smoking cannabis and adopting healthier edible options, which is pushing the market growth,” the article continued. “Furthermore, the common accessibility of CBD-infused drinks such as coffee, fruit punch, cannabis cola, tea, and other CBD-infused beverages across various legal marijuana outlets further augments the global industry.” Noting that CBD is the second most common active component in cannabis, the article observed that the substance is an important component of medicinal marijuana. “Despite the fact that CBD is a component of marijuana, it has no hallucinogenic effects on the human mind. ‘In people, CBD displays no effects suggestive of any misuse or dependency potential,’ according to a World Health Organization report. To date, there has been no evidence of public health issues linked to the use of pure CBD and its derivatives.” F&F reported that CBD beverages are becoming more popular as cannabis-infused goods become legalized across the United States and around the world. “CBD’s appeal has been fueled by its expanding availability combined with a growing health trend, with more and more people opting for ‘better-for-you’ alternatives to sugary drinks. CBD-infused drinks of various types provide a great alternative, with health advantages to boot, because CBD beverages are sourced from a natural source.” Simply Sonoma prides itself on using natural sources for the ingredients it uses. The company has contracted with Sonoma Biologics, a premium hemp cultivator, to grow its strains. The company also has access to some of the best grapes in the world, which Simply Sonoma is using to formulate its CBD-infused grape products. The company has two CBD-infused beverages on the docket: an antioxidant, alcohol-free, CBD wine product and a low-carb, low-sugar Pinot Noir/CBD sparkling product. Simply Sonoma is a different kind of natural company. The company is committed to creating high-quality products using all-natural, organically sun-grown, plant-based ingredients. In addition, because the company is committed to minimizing its carbon footprint, it operates off the grid, relying on solar power. For more information, or to invest in Simply Sonoma, visit the company’s website at www.SimplySonoma.org. NOTE TO INVESTORS: The latest news and updates relating to Simply Sonoma are available in the company’s newsroom at https://ibn.fm/Sonoma

From Our Blog

Longeveron Inc. (NASDAQ: LGVN) Discusses 2023 Progress and 2024 Plans in Corporate Update

March 28, 2024

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicine for life-threatening conditions with unmet medical needs, recently released its full-year results for the period ended December 31, 2023, and provided a corporate update (https://ibn.fm/iORBu). Results from multiple studies using Longeveron’s lead investigational therapeutic candidate, Lomecel-B(TM), were announced by the company last year. “In 2023 […]

Rotate your device 90° to view site.